Selective effects of a fiber chimeric conditionally replicative adenovirus armed with hep27 gene on renal cancer cell

References

• Kim EH, Strope SA. Postoperative surveillance imaging for patients undergoing nephrectomy for renal cell carcinoma. Urologic Oncol 2015; 33(12):499-502; PMID:26411549; http://dx.doi.org/10.1016/j.urolonc
   PubMed Web of Science ®Google Scholar
• Iacovelli R, Modica D, Palazzo A, Trenta P, Piesco G, Cortesi E. Clinical outcome and prognostic factors in renal medullary carcinoma: A pooled analysis from 18 years of medical literature. Can Urol Assoc J 2015; 9:E172-7; PMID:26085875; http://dx.doi.org/10.5489/cuaj.2373
   PubMedGoogle Scholar
• Ko JJ, Xie W, Kroeger N, Lee JL, Rini BI, Knox JJ, Bjarnason GA, Srinivas S, Pal SK, Yuasa T, et al. The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study. Lancet Oncol 2015; 16:293-300; PMID:25681967; http://dx.doi.org/10.1016/S1470-2045(14)71222-7
   PubMed Web of Science ®Google Scholar
• Johnson AG, Ruiz J, Hughes R, Page BR, Isom S, Lucas JT, McTyre ER, Houseknecht KW, Ayala-Peacock DN, Bourland DJ, et al. Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases. Oncotarget 2015; 6:18945-55; PMID:26087184; http://dx.doi.org/10.18632/oncotarget.4153
   PubMed Web of Science ®Google Scholar
• Caratozzolo MF, Valletti A, Gigante M, Aiello I, Mastropasqua F, Marzano F, Ditonno P, Carrieri G, Simonnet H, D'Erchia AM, et al. TRIM8 anti-proliferative action against chemo-resistant renal cell carcinoma. Oncotarget 2014; 5:7446-57; PMID:25277184; http://dx.doi.org/10.18632/oncotarget.2081
   PubMed Web of Science ®Google Scholar
• Jiang H, Gomez-Manzano C, Rivera-Molina Y, Lang FF, Conrad CA, Fueyo J. Oncolytic adenovirus research evolution: from cell-cycle checkpoints to immune checkpoints. Curr Opin Virol 2015; 13:33-9; PMID:25863716; http://dx.doi.org/10.1016/j.coviro.2015.03.009
   PubMed Web of Science ®Google Scholar
• Bressy C, Benihoud K. Association of oncolytic adenoviruses with chemotherapies: an overview and future directions. Biochem Pharmacol 2014; 90:97-106; PMID:24832861; http://dx.doi.org/10.1016/j.bcp.2014.05.003
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang B, Lou J, Yan J, Gao L, Geng R, Yu B. Mutation in fiber of adenovirus serotype 5 gene therapy vector decreases liver tropism. Int J Clin Exp Med 2014; 7:4942-50; PMID:25663991
   PubMed Web of Science ®Google Scholar
• Ballard EN, Trinh VT, Hogg RT, Gerard RD. Peptide targeting of adenoviral vectors to augment tumor gene transfer. Cancer Gene Therapy 2012; 19:476-88; PMID:22595794; http://dx.doi.org/10.1038/cgt.2012.23
   PubMed Web of Science ®Google Scholar
• Takagi-Kimura M, Yamano T, Tamamoto A, Okamura N, Okamura H, Hashimoto-Tamaoki T, Tagawa M, Kasahara N, Kubo S. Enhanced antitumor efficacy of fiber-modified, midkine promoter-regulated oncolytic adenovirus in human malignant mesothelioma. Cancer Sci 2013; 104:1433-9; PMID:23962292; http://dx.doi.org/10.1111/cas.12267
   PubMed Web of Science ®Google Scholar
• Chen W, Wu Y, Liu W, Wang G, Wang X, Yang Y, Chen W, Tai Y, Lu M, Qian Q, et al. Enhanced antitumor efficacy of a novel fiber chimeric oncolytic adenovirus expressing p53 on hepatocellular carcinoma. Cancer Lett 2011; 307:93-103; PMID:21504839; http://dx.doi.org/10.1016/j.canlet.2011.03.021
   PubMed Web of Science ®Google Scholar
• Iguchi K, Sakurai F, Tomita K, Katayama K, Yamaguchi T, Kawabata K, Tagawa M, Kawabata M, Shirakawa T, Mizuguchi H. Efficient antitumor effects of carrier cells loaded with a fiber-substituted conditionally replicating adenovirus on CAR-negative tumor cells. Cancer Gene Ther 2012; 19:118-25; PMID:22076042; http://dx.doi.org/10.1038/cgt.2011.74
   PubMed Web of Science ®Google Scholar
• Gabrielli F, Donadel G, Bensi G, Heguy A, Melli M. A nuclear protein, synthesized in growth-arrested human hepatoblastoma cells, is a novel member of the short-chain alcohol dehydrogenase family. Eur J Biochem / FEBS 1995; 232:473-7; PMID:7556196; http://dx.doi.org/10.1111/j.1432-1033.1995.473zz.x
   PubMedGoogle Scholar
• Pellegrini S, Censini S, Guidotti S, Iacopetti P, Rocchi M, Bianchi M, Covacci A, Gabrielli F. A human short-chain dehydrogenase/reductase gene: structure, chromosomal localization, tissue expression and subcellular localization of its product. Biochim Et Biophysica Acta 2002; 1574:215-22; PMID:1997086; http://dx.doi.org/10.1016/S0167-4781(01)00323-2
   PubMed Web of Science ®Google Scholar
• Shafqat N, Shafqat J, Eissner G, Marschall HU, Tryggvason K, Eriksson U, Gabrielli F, Lardy H, Jörnvall H, Oppermann U. Hep27, a member of the short-chain dehydrogenase/reductase family, is an NADPH-dependent dicarbonyl reductase expressed in vascular endothelial tissue. Cell Mol Life Sci 2006; 63:1205-13; PMID:16685466; http://dx.doi.org/10.1007/s00018-006-6013-y
   PubMed Web of Science ®Google Scholar
• Monge M, Colas E, Doll A, Gil-Moreno A, Castellvi J, Diaz B, Gonzalez M, Lopez-Lopez R, Xercavins J, Carreras R, et al. Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress. Carcinogenesis 2009; 30:1288-97; PMID:19443906; http://dx.doi.org/10.1093/carcin/bgp119
   PubMed Web of Science ®Google Scholar
• Deisenroth C, Thorner AR, Enomoto T, Perou CM, Zhang Y. Mitochondrial Hep27 is a c-Myb target gene that inhibits Mdm2 and stabilizes p53. Mol Cell Biol 2010; 30:3981-93; PMID:20547751; http://dx.doi.org/10.1128/MCB.01284-09
   PubMed Web of Science ®Google Scholar
• Toth K, Dhar D, Wold WS. Oncolytic (replication-competent) adenoviruses as anticancer agents. Exp Opin Biol Ther 2010; 10:353-68; http://dx.doi.org/10.1517/14712590903559822
   PubMed Web of Science ®Google Scholar
• Puntener D, Engelke MF, Ruzsics Z, Strunze S, Wilhelm C, Greber UF. Stepwise loss of fluorescent core protein V from human adenovirus during entry into cells. J Virol 2011; 85:481-96; PMID:21047958; http://dx.doi.org/10.1128/JVI.01571-10
   PubMed Web of Science ®Google Scholar
• Sasaki T, Tazawa H, Hasei J, Osaki S, Kunisada T, Yoshida A, Hashimoto Y, Yano S, Yoshida R, Kagawa S, et al. A simple detection system for adenovirus receptor expression using a telomerase-specific replication-competent adenovirus. Gene therapy 2013; 20:112-8; PMID:22241176; http://dx.doi.org/10.1038/gt.2011.213
   PubMed Web of Science ®Google Scholar
• Fang L, Cheng Q, Bai J, Qi YD, Liu JJ, Li LT, Zheng JN. An oncolytic adenovirus expressing interleukin-24 enhances antitumor activities in combination with paclitaxel in breast cancer cells. Mol Med Rep 2013; 8:1416-24; PMID:24042845; http://dx.doi.org/10.3892/mmr.2013
   PubMed Web of Science ®Google Scholar
• Liu J, Fang L, Cheng Q, Li L, Su C, Zhang B, Pei D, Yang J, Li W, Zheng J. Effects of G250 promoter controlled conditionally replicative adenovirus expressing Ki67-siRNA on renal cancer cell. Cancer Sci 2012; 103:1880-8; PMID:22775978; http://dx.doi.org/10.1111/j.1349-7006.2012.02380.x
   PubMed Web of Science ®Google Scholar
• Hai C, Jin YM, Jin WB, Han ZZ, Cui MN, Piao XZ, Shen XH, Zhang SN, Sun HH. Application of mesenchymal stem cells as a vehicle to deliver replication-competent adenovirus for treating malignant glioma. Chinese J Cancer 2012; 31:233-40; PMID:22429494; http://dx.doi.org/10.5732/cjc.011.10367
   PubMed Web of Science ®Google Scholar
• Takei Y, Okamoto S, Kawamura K, Jiang Y, Morinaga T, Shingyoji M, Sekine I, Kubo S, Tada Y, Tatsumi K, et al. Expression of p53 synergistically augments caspases-mediated apoptosis induced by replication-competent adenoviruses in pancreatic carcinoma cells. Cancer Gene Therapy 2015; 22:445-53; PMID:26251031; http://dx.doi.org/10.1038/cgt.2015.33
   PubMed Web of Science ®Google Scholar
• Jiang G, Liu YQ, Wei ZP, Pei DS, Mao LJ, Zheng JN. Enhanced anti-tumor activity by the combination of a conditionally replicating adenovirus mediated interleukin-24 and dacarbazine against melanoma cells via induction of apoptosis. Cancer letters 2010; 294:220-8; PMID:20189296; http://dx.doi.org/10.1016/j.canlet.2010.02.003
   PubMed Web of Science ®Google Scholar
• Zhang ZL, Zou WG, Luo CX, Li BH, Wang JH, Sun LY, Qian QJ, Liu XY. An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy. Cell Res 2003; 13:481-9; PMID:14728805; http://dx.doi.org/10.1038/sj.cr.7290191
   PubMed Web of Science ®Google Scholar